Portfolio company
Biograil
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Exolvo
This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.
Exolvo Biosciences
Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.
Rani
Rani Therapeutics develops oral capsules that deliver biologic medicines directly into the intestinal wall for patients with chronic conditions requiring regular injections.
Toralgen
This biopharmaceutical company develops nanoparticle technology for the oral delivery of biologics and diabetes medications for pharmaceutical partners and patients.
SEncIL
SEncIL develops encapsulation technology that transforms liquid drugs into polymer-encapsulated powders to improve oral drug delivery for pharmaceutical companies.
Drug Delivery
This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.
Surf Bio
This company develops drug stabilisation and delivery platforms for pharmaceutical manufacturers to enable high-concentration subcutaneous administration of biologics and vaccines.
Ladder Bio
This biotechnology company develops ladder-shaped therapeutic molecules to provide pharmaceutical partners with oral medicines for targets that are currently difficult to drug.